Dr. Xi is a Professor and Department Head in the Department of Pharm & Biomed Sci and the Director of Scientific Career Development at the University of Georgia College of Pharmacy. Before pursuing his PhD, Dr. Xi practiced as a general surgeon. His research focuses on cancer therapeutics, cancer chemoprevention, health disparities, metastasis, immunotherapy, and new drug development. He has received funding for his research projects through various grants, including NIH R01, P20, and R21, as well as the American Cancer Society Research Scholar Award and VA Merit Award.

AREAS OF EXPERTISE
Translational research in breast cancer and colorectal cancer, delving into the underlying mechanisms of cancer initiation and progression, while devising effective strategies to impede these processes.

Cancer drug development and the investigation of molecular mechanisms involving microRNA in the anti-cancereffects of nonsteroidal anti-inflammatory drugs (NSAIDs).

RESEARCH INTERESTS
Cancer drug development and the investigation of molecular mechanisms involving microRNA in the anti-cancer effects of non-steroidal anti-inflammatory drugs (NSAIDs)

Exploring the potential of NSAIDs as novel immune modulators to enhance the response of triple negative breast cancer and colorectal cancer to immune checkpoint inhibitors.

Cancer Therapeutics , Cancer Chemoprevention, Tumor Metastasis, Cancer Drug Discovery and Development, Health Disparities, Immunotherapy